Showing 1251-1260 of 19239 results for "".
Improving Parenteral Nutrition Safety with Multi-Chamber Bag Solutions
https://reachmd.com/programs/gi-insights/improving-parenteral-nutrition-safety-with-multi-chamber-bag-solutions/37243/With the potential to reduce infection risk, improve operational efficiency, and enhance safety through standardization, multi-chamber bags are increasingly being used as an alternative to traditional compounded parenteral nutrition. To explore this approach and how it can be implemented in hospitalExpanding the Role of Hormonal Therapy and Isotretinoin in Acne Care
https://reachmd.com/programs/clinicians-roundtable/hormonal-isotretinoin-acne-care/49089/Explore when and how hormonal therapy and isotretinoin can optimize acne outcomes with Dr. John Barbieri. Challenging outdated assumptions, Dr. Barbieri advocates for broader use of hormonal therapies like spironolactone, clascoterone, and oral contraceptives beyond the traditional subset of adult wMenopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
https://reachmd.com/programs/advances-in-womens-health/hormonal-iuds-perimenopause/48740/Following years of caution surrounding hormone therapy, new guidance and updates have renewed interest in estrogen use for perimenopausal patients. Hormonal intrauterine devices (IUDs) in particular are emerging as a valuable option for supporting endometrial health. Tune in to hear Dr. Mary KatheriNegative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
https://reachmd.com/programs/frontlines-schizophrenia/negative-symptoms-schizophrenia-hidden-burden/36639/While positive symptoms of schizophrenia often take center stage, negative symptoms, such as apathy, anhedonia, and social withdrawal, can be just as disabling. That’s why Dr. Brian McDonough speaks with Dr. Ahmed Makhlouf about the clinical impact of negative symptoms and the tools and therapies thDiagnosing and Treating Hemochromatosis: Expert Insights
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-hemochromatosis-expert-insights/39214/Hemochromatosis, a genetic condition that causes the body to absorb too much iron from food, often goes unrecognized despite its prevalance. With unique diagnostic and management challenges, it's crucial to understand how it presents, which testing strategies are most effective, and what treatment oManaging Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
https://reachmd.com/programs/heart-matters/managing-statin-intolerance-practical-approaches-and-emerging-non-statin-options/37858/Statin intolerance, though uncommon, presents a challenge for patients who experience persistent side effects despite adjustments in dosing or switching statins. Dr. Matthew Sorrentino reviews evidence-baesd alternatives, shares insights on practical use in clinical care, and highlights the latest aTreatment Revolution in IgA Nephropathy
https://reachmd.com/programs/kdigo-conversations-nephrology/treatment-revolution-in-iga-nephropathy/37116/Treatment Revolution in IgA NephropathyExploring Technological Advances in GI Training: Practical Insights for Clinicians
https://reachmd.com/programs/gi-insights/exploring-technological-advances-in-gi-training-practical-insights-for-clinicians/32875/Artificial intelligence, simulation platforms, augmented reality, and other technological innovations are transforming our approach to GI training. In this expert-led discussion, Dr. Peter Buch sits down with Dr. Nabil Mansour to discuss how we can integrate cutting-edge tools into colonoscopy trainAre Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
https://reachmd.com/programs/project-oncology/are-subcutaneous-immunotherapies-expanding-access-and-efficiency-in-cancer-care/36401/Subcutaneous immunotherapies are emerging as a promising alternative to traditional IV delivery for immune checkpoint inhibitors, demonstrating comparable safety and efficacy along with meaningful time savings. But reimbursement gaps, dosing complexities, and biosimilar competition present challengeAdvances in Pediatric Eczema Care: Emerging Biologics, JAK Inhibitors, and Beyond
https://reachmd.com/programs/dermconsult/advances-in-pediatric-eczema-care-emerging-biologics-jak-inhibitors-and-beyond/35500/Between four FDA-approved biologics, two oral JAK inhibitors, and an exciting pipeline that features novel therapies and extended dosing innovations, the treatment of pediatric eczema is rapidly evolving. Catch up on the latest updates and where the landscape is headed with Dr. Peter Lio, Clinical A